AGMB AGOMAB THERAPEUTICS NV
FollowSPONSORED ADS (ADR), issuer CIK 2020932
32 managers (32 13F filers) reported a position in AGMB shares at 2026-03-31, 23,354,227 shares in all. 32 filers opened a position and 0 filers sold out during the quarter.
- Managers
- 32
- 13F filers
- 32
- New
- 32
- Added
- 0
- Reduced
- 0
- Sold out
- 0
- Shares held by filers
- 23,354,227
Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.
13D and 13G filers
No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.
Insider trades
| Owner | Date | Shares | Price | Filing |
|---|---|---|---|---|
| Epstein David Rdirector | 2026-10-08 | +5,000 P | $8.9 | Form 4 |
| Epstein David Rdirector | 2026-10-06 | +5,000 P | $8.7 | Form 4 |
| Kemula Pierre Thadee Victorofficer (Chief Financial Officer) | 2026-10-06 | +2,000 P | $8.54 | Form 4 |
| Kemula Pierre Thadee Victorofficer (Chief Financial Officer) | 2026-10-06 | +5,000 P | $8.57 | Form 4 |
| Kemula Pierre Thadee Victorofficer (Chief Financial Officer) | 2026-10-06 | +3,000 P | $8.67 | Form 4 |
| Knotnerus Tim Jasperdirector, officer (Chief Executive Officer) | 2026-10-06 | +5,000 P | $8.7 | Form 4 |
| Epstein David Rdirector | 2026-10-05 | +5,000 P | $8.57 | Form 4 |
| Knotnerus Tim Jasperdirector, officer (Chief Executive Officer) | 2026-10-05 | +6,000 P | $8.48 | Form 4 |
13F holders, Q1 2026
Filers in the available 13F reports with a share position at 2026-03-31, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
| Holder | Shares | Value | % of portfolio | Change | Source |
|---|---|---|---|---|---|
| EQT Fund Management S.a r.l. | 5,141,992 | $53.9M | 5.28% | new | 13F-HRTimeline |
| Sanofi | 2,783,096 | $29.2M | 8.69% | new | 13F-HRTimeline |
| Cormorant Asset Management, LP | 2,465,348 | $25.9M | 1.3% | new | 13F-HRTimeline |
| TCG Crossover Management, LLC | 2,053,233 | $21.5M | 0.62% | new | 13F-HRTimeline |
| FEDERATED HERMES, INC.in group FEDERATED HERMES, INC. | 1,618,000 | $17M | 0.03% | new | 13F-HRTimelineGroup |
| Casdin Capital, LLC | 1,550,000 | $16.3M | 1.23% | new | 13F-HRTimeline |
| ANDERA PARTNERS | 1,538,702 | $16.1M | 9.12% | new | 13F-HRTimeline |
| FMR LLCin group FMR LLC | 1,458,677 | $15.3M | <0.01% | new | 13F-HRTimelineGroup |
| Nantahala Capital Management, LLCin group Nantahala Capital Management,… | 1,200,000 | $12.9M | 0.8% | new | 13F-HRTimelineGroup |
| Aberdeen Group plcin group Aberdeen Group plc | 707,656 | $7.42M | 0.01% | new | 13F-HRTimelineGroup |
| PERCEPTIVE ADVISORS LLCin group PERCEPTIVE ADVISORS LLC | 600,000 | $6.29M | 0.12% | new | 13F-HR/ATimelineGroup |
| SAMSARA BIOCAPITAL, LLC | 600,000 | $6.29M | 0.61% | new | 13F-HRTimeline |
| Siren, L.L.C.in group Siren, L.L.C. | 411,250 | $4.31M | 0.12% | new | 13F-HRTimelineGroup |
| LMR Partners LLPin group LMR Partners LLP | 300,000 | $3.15M | 0.03% | new | 13F-HRTimelineGroup |
| SEVEN GRAND MANAGERS, LLC | 200,000 | $2.1M | 0.14% | new | 13F-HRTimeline |
| Redmile Group, LLCin group Redmile Group, LLC | 156,250 | $1.64M | 0.11% | new | 13F-HRTimelineGroup |
| MILLENNIUM MANAGEMENT LLCin group MILLENNIUM MANAGEMENT LLC | 95,233 | $999K | <0.01% | new | 13F-HRTimelineGroup |
| Pfizer Inc | 75,000 | $814K | 0.34% | new | 13F-HRTimeline |
| Alyeska Investment Group, L.P.in group Alyeska Investment Group, L.P. | 75,000 | $787K | <0.01% | new | 13F-HRTimelineGroup |
| Laurion Capital Management LP | 50,000 | $524K | 0.05% | new | 13F-HRTimeline |
| Bellevue Group AGin group Bellevue Group AG | 50,000 | $524K | 0.01% | new | 13F-HRTimelineGroup |
| SECTORAL ASSET MANAGEMENT INC | 43,500 | $477K | 0.4% | new | 13F-HRTimeline |
| GOLDMAN SACHS GROUP INCin group GOLDMAN SACHS GROUP INC | 35,739 | $375K | <0.01% | new | 13F-HRTimelineGroup |
| CITADEL ADVISORS LLCin group CITADEL ADVISORS LLC | 35,000 | $367K | <0.01% | new | 13F-HRTimelineGroup |
| Burkehill Global Management, LP | 35,000 | $367K | 0.02% | new | 13F-HRTimeline |
| HRT FINANCIAL LP | 23,726 | $248K | <0.01% | new | 13F-HRTimeline |
| D. E. Shaw & Co., Inc.in group D. E. Shaw & Co., Inc. | 15,326 | $161K | <0.01% | new | 13F-HRTimelineGroup |
| TWO SIGMA INVESTMENTS, LPin group TWO SIGMA INVESTMENTS, LP | 14,241 | $149K | <0.01% | new | 13F-HRTimelineGroup |
| JANE STREET GROUP, LLCin group JANE STREET GROUP, LLC | 12,794 | $134K | <0.01% | new | 13F-HRTimelineGroup |
| UBS Group AGin group UBS Group AG | 6,437 | $67.5K | <0.01% | new | 13F-HRTimelineGroup |
| MORGAN STANLEYin group MORGAN STANLEY | 3,025 | $31.7K | <0.01% | new | 13F-HRTimelineGroup |
| SBI Securities Co., Ltd. | 2 | $21 | <0.01% | new | 13F-HRTimeline |
Events
Epstein David R bought 5,000 AGMB shares on 2026-10-08, Form 4 filed 2026-10-09. 0001445826-26-000014
Accepted , ingestedEpstein David R bought 10,000 AGMB shares between 2026-10-05 and 2026-10-06, Form 4 filed 2026-10-07. 0001445826-26-000013
Accepted , ingestedKemula Pierre Thadee Victor bought 10,000 AGMB shares on 2026-10-06, Form 4 filed 2026-10-07. 0002119332-26-000001
Accepted , ingestedKnotnerus Tim Jasper bought 11,000 AGMB shares between 2026-10-05 and 2026-10-06, Form 4 filed 2026-10-07. 0002120886-26-000001
Accepted , ingested